7,309 Shares in Hawkins, Inc. $HWKN Purchased by Zions Bancorporation National Association UT

Zions Bancorporation National Association UT purchased a new stake in shares of Hawkins, Inc. (NASDAQ:HWKN) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 7,309 shares of the specialty chemicals company’s stock, valued at approximately $1,336,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Hawkins by 2.8% during the third quarter. Vanguard Group Inc. now owns 1,504,831 shares of the specialty chemicals company’s stock worth $274,963,000 after buying an additional 41,652 shares during the last quarter. State of New Jersey Common Pension Fund D acquired a new stake in Hawkins in the 3rd quarter valued at about $2,312,000. PNC Financial Services Group Inc. grew its holdings in Hawkins by 0.6% during the third quarter. PNC Financial Services Group Inc. now owns 12,708 shares of the specialty chemicals company’s stock worth $2,322,000 after purchasing an additional 79 shares during the period. Public Sector Pension Investment Board increased its position in Hawkins by 26.1% during the third quarter. Public Sector Pension Investment Board now owns 81,402 shares of the specialty chemicals company’s stock worth $14,874,000 after buying an additional 16,850 shares during the last quarter. Finally, Rhumbline Advisers raised its stake in Hawkins by 10.8% in the third quarter. Rhumbline Advisers now owns 59,135 shares of the specialty chemicals company’s stock valued at $10,805,000 after buying an additional 5,778 shares during the period. Institutional investors own 69.71% of the company’s stock.

Insider Buying and Selling

In related news, Director James A. Faulconbridge bought 1,500 shares of the company’s stock in a transaction dated Wednesday, February 4th. The stock was purchased at an average price of $129.29 per share, with a total value of $193,935.00. Following the completion of the acquisition, the director owned 50,907 shares of the company’s stock, valued at $6,581,766.03. The trade was a 3.04% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 4.10% of the company’s stock.

Hawkins Trading Up 1.7%

Shares of NASDAQ:HWKN opened at $146.61 on Tuesday. The business’s 50 day simple moving average is $145.65 and its 200 day simple moving average is $154.49. Hawkins, Inc. has a 1 year low of $98.30 and a 1 year high of $186.15. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.35 and a quick ratio of 1.46. The company has a market capitalization of $3.06 billion, a P/E ratio of 37.12, a P/E/G ratio of 3.10 and a beta of 0.86.

Hawkins (NASDAQ:HWKN) last released its earnings results on Wednesday, January 28th. The specialty chemicals company reported $0.72 earnings per share for the quarter, missing analysts’ consensus estimates of $0.75 by ($0.03). Hawkins had a net margin of 7.75% and a return on equity of 16.85%. The company had revenue of $244.08 million for the quarter, compared to the consensus estimate of $252.51 million. On average, research analysts anticipate that Hawkins, Inc. will post 4 EPS for the current fiscal year.

Hawkins Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 27th. Shareholders of record on Friday, February 13th will be given a $0.19 dividend. This represents a $0.76 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date is Friday, February 13th. Hawkins’s payout ratio is currently 19.24%.

Analyst Upgrades and Downgrades

HWKN has been the subject of several research analyst reports. Weiss Ratings downgraded Hawkins from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, January 12th. BWS Financial reissued a “buy” rating and issued a $200.00 price objective on shares of Hawkins in a research report on Thursday, January 29th. Finally, Zacks Research upgraded shares of Hawkins from a “strong sell” rating to a “hold” rating in a research note on Friday, January 2nd. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat, Hawkins currently has a consensus rating of “Hold” and an average target price of $162.50.

Hawkins Profile

Hawkins, Inc (NASDAQ: HWKN) is a specialty chemical company that produces and distributes water-treatment and industrial chemicals across North America. Founded in 1938 and headquartered in Roseville, Minnesota, the company has built a network of manufacturing facilities and distribution centers that serve municipal, industrial and commercial customers. As a publicly traded entity, Hawkins leverages its long-standing presence in the chemical distribution industry to provide tailored solutions for complex water-treatment challenges and specialty chemical needs.

Hawkins’ product portfolio encompasses a wide range of chemicals, including sodium hypochlorite, sodium hydroxide, hydrogen peroxide, chlorine, acids and specialty blends.